AbbVie (ABBV) Price to Earnings (2012 - 2026)
AbbVie's (ABBV) quarterly Price to Earnings came in at 122.97 in Q2 2026, down 64.71% year-over-year from 348.47 in Q2 2025, and down 77.69% quarter-over-quarter from 551.31 in Q1 2026.
Powered by 
Analysis
AbbVie (ABBV) Price to Earnings (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Price to Earnings for 15 consecutive years, with 122.97 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Earnings fell 64.71% year-over-year to 122.97 in Q2 2026; TTM through Jun 2026 was 70.4, a 19.03% decrease from a year earlier, with the FY2025 full-year figure at 95.44, up 30.4% from the prior year.
- Price to Earnings was 122.97 for Q2 2026 at AbbVie, down from 551.31 in the prior quarter.
- Over five years, Price to Earnings peaked at 2176.7 in Q3 2025 and troughed at 13639.28 in Q4 2024.
- A 5-year average of 612.34 and a median of 221.63 in 2024 frame the typical range for Price to Earnings.
- Across the five-year window, Price to Earnings sank 4646.4% in 2023 and soared 875.53% in 2025, its largest moves.
- Over 5 years, Price to Earnings stood at 115.68 in 2022, then surged by 187.2% to 332.22 in 2023, then sank by 4205.48% to 13639.28 in 2024, then soared by 101.63% to 222.59 in 2025, then plunged by 44.75% to 122.97 in 2026.
- The last three Price to Earnings figures came in at 122.97 (Q2 2026), 551.31 (Q1 2026), and 222.59 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.97 |
| Mar 31, 2026 | 551.31 |
| Dec 31, 2025 | 222.59 |
| Sep 30, 2025 | 2,176.70 |
| Jun 30, 2025 | 348.47 |
| Mar 31, 2025 | 287.12 |
| Dec 31, 2024 | -13,639.28 |
| Sep 30, 2024 | 223.13 |
| Jun 30, 2024 | 220.66 |
| Mar 31, 2024 | 234.38 |
| Dec 31, 2023 | 332.22 |
| Sep 30, 2023 | 147.77 |
| Jun 30, 2023 | 117.32 |
| Mar 31, 2023 | -2,898.71 |
| Dec 31, 2022 | 115.68 |
| Sep 30, 2022 | 60.06 |
| Jun 30, 2022 | 291.81 |
| Mar 31, 2022 | 63.76 |
| Dec 31, 2021 | 59.21 |
| Sep 30, 2021 | 59.97 |